Document is current

Any future updates will be listed below

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies

Crossref DOI link: https://doi.org/10.1038/s41433-026-04460-x

Published Online: 2026-05-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark